The antral follicle count (AFC) was comparable between the two groups (p > 0.05), and the AMH levels in the breast cancer group were found not to be significantly different to those in the non-cancer group (2.83 [0.81–9.15] ng/mL vs. 2.58 [0.7–9.2]; p-value =0.23). The gene discussed is AMH; the disease is breast carcinoma.